Humana Inc. (NYSE:HUM) Shares Sold by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board lessened its holdings in shares of Humana Inc. (NYSE:HUM) by 14.6% in the second quarter, according to its most recent filing with the SEC. The firm owned 450,144 shares of the insurance provider’s stock after selling 77,081 shares during the quarter. Canada Pension Plan Investment Board owned about 0.37% of Humana worth $168,196,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Intech Investment Management LLC increased its stake in shares of Humana by 46.2% during the fourth quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock valued at $19,359,000 after acquiring an additional 13,356 shares during the period. AdvisorShares Investments LLC bought a new position in Humana during the fourth quarter valued at about $421,000. Sei Investments Co. grew its holdings in Humana by 0.4% during the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after acquiring an additional 264 shares during the period. Cetera Advisors LLC raised its position in Humana by 472.1% in the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after acquiring an additional 8,333 shares in the last quarter. Finally, Cetera Investment Advisers lifted its holdings in Humana by 249.0% in the 1st quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock valued at $7,262,000 after acquiring an additional 14,944 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Trading Down 0.5 %

Shares of NYSE HUM opened at $310.41 on Friday. The business has a 50 day simple moving average of $357.71 and a 200 day simple moving average of $345.63. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54. The stock has a market cap of $37.40 billion, a price-to-earnings ratio of 19.33, a PEG ratio of 2.56 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter last year, the firm earned $8.94 EPS. Humana’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, research analysts predict that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date is Monday, September 30th. Humana’s dividend payout ratio is 22.04%.

Wall Street Analyst Weigh In

Several analysts recently commented on HUM shares. Robert W. Baird initiated coverage on shares of Humana in a research note on Thursday, May 30th. They set a “neutral” rating and a $374.00 target price for the company. Deutsche Bank Aktiengesellschaft raised their price objective on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. JPMorgan Chase & Co. boosted their target price on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Oppenheimer increased their price target on Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st. Finally, Royal Bank of Canada boosted their price objective on Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, September 5th. Thirteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $398.70.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.